Search for "T-shaped" in Full Text gives 34 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2025, 21, 1808–1853, doi:10.3762/bjoc.21.143
Graphical Abstract
Figure 1: Energy diagram of a two-state photoswitch. Figure 1 was redrawn from [2].
Figure 2: Example of the absorption spectra of the isomers of a photoswitch with most efficient irradiation w...
Scheme 1: Photoswitch classes described in this review.
Figure 3: Azoheteroarenes.
Scheme 2: E–Z Isomerisation (top) and mechanisms of thermal Z–E isomerisation (bottom).
Scheme 3: Rotation mechanism favoured by the electron displacement in push–pull systems. Selected examples of...
Figure 4: A) T-shaped and twisted Z-isomers determine the thermal stability and the Z–E-PSS (selected example...
Figure 5: Effect of di-ortho-substitution on thermal half-life and PSS.
Figure 6: Selected thermal lifetimes of azoindoles in different solvents and concentrations. aConcentration o...
Figure 7: Aryliminopyrazoles: N-pyrazoles (top) and N-phenyl (bottom).
Scheme 4: Synthesis of symmetrical heteroarenes through oxidation (A), reduction (B), and the Bayer–Mills rea...
Scheme 5: Synthesis of diazonium salt (A); different strategies of azo-coupling: with a nucleophilic ring (B)...
Scheme 6: Synthesis of arylazothiazoles 25 (A) and heteroaryltriazoles 28 (B).
Scheme 7: Synthesis of heteroarylimines 31a,b [36-38].
Figure 8: Push–pull non-ionic azo dye developed by Velasco and co-workers [45].
Scheme 8: Azopyridine reported by Herges and co-workers [46].
Scheme 9: Photoinduced phase transitioning azobispyrazoles [47].
Figure 9: Diazocines.
Scheme 10: Isomers, conformers and enantiomers of diazocine.
Scheme 11: Partial overlap of the ππ* band with electron-donating substituents and effect on the PSS. Scheme 11 was ada...
Figure 10: Main properties of diazocines with different bridges. aMeasured in n-hexane [56]. bMeasured in THF. cMe...
Scheme 12: Synthesis of symmetric diazocines.
Scheme 13: Synthesis of asymmetric diazocines.
Scheme 14: Synthesis of O- and S-heterodiazocines.
Scheme 15: Synthesis of N-heterodiazocines.
Scheme 16: Puromycin diazocine photoswitch [60].
Figure 11: Indigoids.
Figure 12: The main representatives of the indigoid photoswitch class.
Scheme 17: Deactivation process that prevents Z-isomerisation of indigo.
Figure 13: Stable Z-indigo derivative synthesised by Wyman and Zenhäusern [67].
Figure 14: Selected examples of indigos with aliphatic and aromatic substituents [68]. Dashed box: proposed π–π in...
Scheme 18: Resonance structures of indigo and thioindigo involving the phenyl ring.
Scheme 19: Possible deactivation mechanism for 4,4'-dihydroxythioindigo [76].
Scheme 20: Effect of different heteroaryl rings on the stability and the photophysical properties of hemiindig...
Figure 15: Thermal half-lives of red-shifted hemithioindigos in toluene [79]. aMeasured in toluene-d8.
Scheme 21: Structures of pyrrole [81] and imidazole hemithioindigo [64].
Figure 16: Examples of fully substituted double bond hemithioindigo (left), oxidised hemithioindigos (centre),...
Scheme 22: Structure of iminothioindoxyl 72 (top) and acylated phenyliminoindolinone photoswitch 73 (bottom). ...
Scheme 23: (top) Transition states of iminothioindoxyl 72. The planar transition state is associated with a lo...
Scheme 24: Baeyer–Drewsen synthesis of indigo (top) and N-functionalisation strategies (bottom).
Scheme 25: Synthesis of hemiindigo.
Scheme 26: Synthesis of hemithioindigo and iminothioindoxyl.
Scheme 27: Synthesis of double-bond-substituted hemithioindigos.
Scheme 28: Synthesis of phenyliminoindolinone.
Scheme 29: Hemithioindigo molecular motor [85].
Figure 17: Arylhydrazones.
Scheme 30: Switching of arylhydrazones. Note: The definitions of stator and rotor are arbitrary.
Scheme 31: Photo- and acidochromism of pyridine-based phenylhydrazones.
Scheme 32: A) E–Z thermal inversion of a thermally stable push–pull hydrazone [109]. B) Rotation mechanism favoured...
Scheme 33: Effect of planarisation on the half-life.
Scheme 34: The longest thermally stable hydrazone switches reported so far (left). Modulation of thermal half-...
Figure 18: Dependency of t1/2 on concentration and hypothesised aggregation-induced isomerisation.
Figure 19: Structure–property relationship of acylhydrazones.
Scheme 35: Synthesis of arylhydrazones.
Scheme 36: Synthesis of acylhydrazones.
Scheme 37: Photoswitchable fluorophore by Aprahamian et al. [115].
Scheme 38: The four-state photoswitch synthesised by the Cigáň group [116].
Figure 20: Diarylethenes.
Scheme 39: Isomerisation and oxidation pathway of E-stilbene to phenanthrene.
Scheme 40: Strategies adapted to avoid E–Z isomerisation and oxidation.
Scheme 41: Molecular orbitals and mechanism of electrocyclisation for a 6π system.
Figure 21: Aromatic stabilisation energy correlated with the thermal stability of the diarylethenes [127,129].
Figure 22: Half-lives of diarylethenes with increasing electron-withdrawing groups [128,129].
Scheme 42: Photochemical degradation pathway promoted by electron-donating groups [130].
Figure 23: The diarylethenes studied by Hanazawa et al. [134]. Increased rigidity leads to bathochromic shift.
Scheme 43: The dithienylethene synthesised by Nakatani's group [135].
Scheme 44: Synthesis of perfluoroalkylated diarylethenes.
Scheme 45: Synthesis of 139 and 142 via McMurry coupling.
Scheme 46: Synthesis of symmetrical derivatives 145 via Suzuki–Miyaura coupling.
Scheme 47: Synthesis of acyclic 148, malonic anhydride 149, and maleimide derivatives 154.
Figure 24: Gramicidin S (top left) and two of the modified diarylethene derivatives: first generation (bottom ...
Scheme 48: Pyridoxal 5'-phosphate and its reaction with an amino acid (top). The analogous dithienylethene der...
Figure 25: Fulgides.
Scheme 49: The three isomers of fulgides.
Scheme 50: Thermal and photochemical side products of unsubstituted fulgide [150].
Figure 26: Maximum absorption λc of the closed isomer compared with the nature of the aromatic ring and the su...
Scheme 51: Possible rearrangement of the excited state of 5-dimethylaminoindolylfulgide [153].
Figure 27: Quantum yields of ring closure (ΦE→C) and E–Z isomerisation (ΦE→Z) correlated with the increasing s...
Scheme 52: Active (Eα) and inactive (Eβ) conformers (left) and the bicyclic sterically blocked fulgide 169 (ri...
Scheme 53: Quantum yield of ring-opening (ΦC→E) and E–Z isomerisation (ΦE→Z) for different substitution patter...
Scheme 54: Stobbe condensation pathway for the synthesis of fulgides 179, fulgimides 181 and fulgenates 178.
Scheme 55: Alternative synthesis of fulgides through Pd-catalysed carbonylation.
Scheme 56: Optimised synthesis of fulgimides [166].
Scheme 57: Photoswitchable FRET with a fulgimide photoswitch [167].
Scheme 58: Three-state fulgimide strategy by Slanina's group.
Figure 28: Spiropyrans.
Scheme 59: Photochemical (left) and thermal (right) ring-opening mechanisms for an exemplary spiropyran with a...
Figure 29: Eight possible isomers of the open merocyanine according to the E/Z configurations of the bonds hig...
Scheme 60: pH-Controlled photoisomerisation between the closed spiropyran 191-SP and the open E-merocyanine 19...
Scheme 61: Behaviour of spiropyran in water buffer according to Andréasson and co-workers [180]. 192-SP in an aqueo...
Scheme 62: (left box) Proposed mechanism of basic hydrolysis of MC [184]. (right box) Introduction of electron-dona...
Scheme 63: Photochemical interconversion of naphthopyran 194 (top) and spirooxazine 195 (bottom) photoswitches...
Scheme 64: Synthesis of spiropyrans and spirooxazines 198 and the dicondensation by-product 199.
Scheme 65: Alternative synthesis of spiropyrans and spirooxazines with indolenylium salt 200.
Scheme 66: Synthesis of 4’-substituted spiropyrans 203 by condensation of an acylated methylene indoline 201 w...
Scheme 67: Synthesis of spironaphthopyrans 210 by acid-catalysed condensation of naphthols and diarylpropargyl...
Scheme 68: Photoswitchable surface wettability [194].
Figure 30: Some guiding principles for the choice of the most suitable photoswitch. Note that this guide is ve...
Beilstein J. Org. Chem. 2025, 21, 1095–1103, doi:10.3762/bjoc.21.87
Graphical Abstract
Figure 1: (A) Our previous work: Assembly and disassembly of phenylalanine hypervalent iodine macrocycles (Ph...
Figure 2: Two conformations of the HIM were found. One conformation projected all three benzyl groups in a ve...
Figure 3: A) Chemical structure of HIM 1: Three iodine atoms and three inward projected ester carbonyls curcu...
Figure 4: 1H NMR titration experiment of 1 with LiBArF20 at an incremental equivalency in CDCl3 and (CD3)2CO ...
Figure 5: Crystal structures of HIM 1 and LiBArF20 (A) and NaBArF24 (B). BARF cation is omitted for clarity. ...
Figure 6: Alternative view of the crystal structure of the HIM 1 and LiBArF20 complex. BArF20 anion is omitte...
Figure 7: Isotherms of 1 titrated with NaBArF24 orLiBArF20. The solid lines are the predicted model fits for ...
Figure 8: Lithium complex 2 (red) overlaid with lithium complex 3 (blue). In lithium complex 2, one benzyl ri...
Beilstein J. Org. Chem. 2024, 20, 3281–3289, doi:10.3762/bjoc.20.272
Graphical Abstract
Figure 1: Examples of cyclic HIRs with a nitrogen-based group transfer [4,10,13-20].
Scheme 1: Electrophilic α‑amination of indanone-based β-ketoesters [4].
Scheme 2: Scope of the different (benzylamino)benziodoxolones (BBXs) 2 with ORTEP-3 diagram of compound 2d, u...
Scheme 3: Scope of the different β-sulfinyl esters 4 [32,33]. Isolated yields. rt – room temperature.
Scheme 4: Scope of the primary amine electrophilic reaction of sulfenate salts. Reaction conditions: 4 (2 equ...
Scheme 5: Electrophilic amination reaction in the presence of TEMPO. Reaction conditions: 4a (2 equiv), NaH (...
Scheme 6: Mechanism proposed for sulfonamide 5, β-sulfinyl ester 4, disulfide 7, and sulfide 3 formations. Th...
Beilstein J. Org. Chem. 2024, 20, 2931–2939, doi:10.3762/bjoc.20.245
Graphical Abstract
Figure 1: Structure and stability of hypervalent iodine compounds.
Figure 2: Phosphorus-iodonium ylids investigated in this study: Yields (for synthetic procedures, see Supporting Information File 1), stru...
Figure 3: (a) Selected TGA thermograms of phosphorus-iodonium ylids at 10 °C min−1 in N2 (full dataset in Supporting Information File 1). ...
Figure 4: (a) Proposed decomposition mechanism based on ex situ analysis (1H, 31P NMR, ESI-MS) following abor...
Beilstein J. Org. Chem. 2024, 20, 1839–1879, doi:10.3762/bjoc.20.162
Graphical Abstract
Scheme 1: Mechanism of the GBB reaction.
Scheme 2: Comparison of the performance of Sc(OTf)3 with some RE(OTf)3 in a model GBB reaction. Conditions: a...
Scheme 3: Comparison of the performance of various Brønsted acid catalysts in the synthesis of GBB adduct 6. ...
Scheme 4: Synthesis of Brønsted acidic ionic liquid catalyst 7. Conditions: a) neat, 60 °C, 24 h; b) TfOH, DC...
Scheme 5: Aryliodonium derivatives as organic catalysts in the GBB reaction. In the box the proposed binding ...
Scheme 6: DNA-encoded GBB reaction in micelles made of amphiphilic polymer 13. Conditions: a) 13 (50 equiv), ...
Scheme 7: GBB reaction catalyzed by cyclodextrin derivative 14. Conditions: a) 14 (1 mol %), water, 100 °C, 4...
Scheme 8: Proposed mode of activation of CALB. a) activation of the substrates; b) activation of the imine; c...
Scheme 9: One-pot GBB reaction–Suzuki coupling with a bifunctional hybrid biocatalyst. Conditions: a) Pd(0)-C...
Scheme 10: GBB reaction employing 5-HMF (23) as carbonyl component. Conditions: a) TFA (20 mol %), EtOH, 60 °C...
Scheme 11: GBB reaction with β-C-glucopyranosyl aldehyde 26. Conditions: a) InCl3 (20 mol %), MeOH, 70 °C, 2–3...
Scheme 12: GBB reaction with diacetylated 5-formyldeoxyuridine 29, followed by deacetylation of GBB adduct 30....
Scheme 13: GBB reaction with glycal aldehydes 32. Conditions: a) HFIP, 25 °C, 2–4 h.
Scheme 14: Vilsmeier–Haack formylation of 6-β-acetoxyvouacapane (34) and subsequent GBB reaction. Conditions: ...
Scheme 15: GBB reaction of 4-formlyl-PCP 37. Conditions: a) HOAc or HClO4, MeOH/DCM (2:3), rt, 3 d.
Scheme 16: GBB reaction with HexT-aldehyde 39. Conditions: a) 39 (20 nmol) and amidine (20 μmol), MeOH, rt, 6 ...
Scheme 17: GBB reaction of 2,4-diaminopirimidine 41. Conditions: a) Sc(OTf)3 (20 mol %), MeCN, 120 °C (MW), 1 ...
Scheme 18: Synthesis of N-edited guanine derivatives from 3,6-diamine-1,2,4-triazin-5-one 44. Conditions: a) S...
Scheme 19: Synthesis of 2-aminoimidazoles 49 by a Mannich-3CR followed by a one-pot intramolecular oxidative a...
Scheme 20: On DNA Suzuki–Miyaura reaction followed by GBB reaction. Conditions: a) CsOH, sSPhos-Pd-G2; b) AcOH...
Scheme 21: One-pot cascade synthesis of 5-iminoimidazoles. Conditions: a) Na2SO4, DMF, 220 °C (MW).
Scheme 22: GBB reaction of 5-amino-1H-imidazole-4-carbonile 57. Conditions: a) HClO4 (5 mol %), MeOH, rt, 24 h....
Scheme 23: One-pot cascade synthesis of indole-imidazo[1,2,a]pyridine hybrids. In blue the structural motif in...
Scheme 24: One-pot cascade synthesis of fused polycyclic indoles 67 or 69 from indole-3-carbaldehyde. Conditio...
Scheme 25: One-pot cascade synthesis of linked- and bridged polycyclic indoles from indole-2-carbaldehyde (70)...
Scheme 26: One-pot cascade synthesis of pentacyclic dihydroisoquinolines (X = N or CH). In blue the structural...
Scheme 27: One-pot stepwise synthesis of imidazopyridine-fused benzodiazepines 85. Conditions: a) p-TsOH (20 m...
Scheme 28: One-pot stepwise synthesis of benzoxazepinium-fused imidazothiazoles 89. Conditions: a) Yb(OTf)3 (2...
Scheme 29: One-pot stepwise synthesis of fused imidazo[4,5,b]pyridines 95. Conditions: a) HClO4, MeOH, rt, ove...
Scheme 30: Synthesis of heterocyclic polymers via the GBB reaction. Conditions: a) p-TsOH, EtOH, 70 °C, 24 h.
Scheme 31: One-pot multicomponent reaction towards the synthesis of covalent organic frameworks via the GBB re...
Scheme 32: One-pot multicomponent reaction towards the synthesis of covalent organic frameworks via the GBB re...
Scheme 33: GBB-like multicomponent reaction towards the synthesis of benzothiazolpyrroles (X = S) and benzoxaz...
Scheme 34: GBB-like multicomponent reaction towards the formation of imidazo[1,2,a]pyridines. Conditions: a) I2...
Scheme 35: Post-functionalization of GBB products via Ugi reaction. Conditions a) HClO4, DMF, rt, 24 h; b) MeO...
Scheme 36: Post-functionalization of GBB products via Click reaction. Conditions: a) solvent-free, 150 °C, 24 ...
Scheme 37: Post-functionalization of GBB products via cascade alkyne–allene isomerization–intramolecular nucle...
Scheme 38: Post-functionalization of GBB products via metal-catalyzed intramolecular N-arylation. In red and b...
Scheme 39: Post-functionalization of GBB products via isocyanide insertion (X = N or CH). Conditions: a) HClO4...
Scheme 40: Post-functionalization of GBB products via intramolecular nucleophilic addition to nitriles. Condit...
Scheme 41: Post-functionalization of GBB products via Pictet–Spengler cyclization. Conditions: a) 4 N HCl/diox...
Scheme 42: Post-functionalization of GBB products via O-alkylation. Conditions: a) TFA (20 mol %), EtOH, 120 °...
Scheme 43: Post-functionalization of GBB products via macrocyclization (X = -CH2CH2O-, -CH2-, -(CH2)4-). Condi...
Figure 1: Antibacterial activity of GBB-Ugi adducts 113 on both Gram-negative and Gram-positive strains.
Scheme 44: GBB multicomponent reaction using trimethoprim as the precursor. Conditions: a) Yb(OTf)3 or Y(OTf)3...
Figure 2: Antibacterial activity of GBB adducts 152 against MRSA and VRE; NA = not available.
Figure 3: Antibacterial activity of GBB adduct 153 against Leishmania amazonensis promastigotes and amastigot...
Figure 4: Antiviral and anticancer evaluation of the GBB adducts 154a and 154b. In vitro antiproliferative ac...
Figure 5: Anticancer activity of the GBB-furoxan hybrids 145b, 145c and 145d determined through antiprolifera...
Scheme 45: Synthesis and anticancer activity of the GBB-gossypol conjugates. Conditions: a) Sc(OTf)3 (10 mol %...
Figure 6: Anticancer activity of polyheterocycles 133a and 136a against human neuroblastoma. Clonogenic assay...
Figure 7: Development of GBB-adducts 158a and 158b as PD-L1 antagonists. HTRF assays were carried out against...
Figure 8: Development of imidazo[1,2-a]pyridines and imidazo[1,2-a]pyrazines as TDP1 inhibitors. The SMM meth...
Figure 9: GBB adducts 164a–c as anticancer through in vitro HDACs inhibition assays. Additional cytotoxic ass...
Figure 10: GBB adducts 165, 166a and 166b as anti-inflammatory agents through HDAC6 inhibition; NA = not avail...
Scheme 46: GBB reaction of triphenylamine 167. Conditions: a) NH4Cl (10 mol %), MeOH, 80 °C (MW), 1 h.
Scheme 47: 1) Modified GBB-3CR. Conditions: a) TMSCN (1.0 equiv), Sc(OTf)3 (0.2 equiv), MeOH, 140 °C (MW), 20 ...
Scheme 48: GBB reaction to assemble imidazo-fused heterocycle dimers 172. Conditions: a) Sc(OTf)3 (20 mol %), ...
Figure 11: Model compounds 173 and 174, used to study the acid/base-triggered reversible fluorescence response...
Beilstein J. Org. Chem. 2024, 20, 1486–1496, doi:10.3762/bjoc.20.132
Graphical Abstract
Figure 1: (A) Selected monovalent inhibitors for PA LecA and (B) designed general structure of photoswitchabl...
Scheme 1: Synthesis of photoswitchable LecA inhibitors. Reagents and conditions: (i) DMC, Et3N, H2O, −10 °C t...
Figure 2: (Left) Absorption spectra and (right) fatigue resistance of 1 under alternated 370/485 nm irradiati...
Figure 3: 1H NMR (400 MHz) spectra of E-1 (black line), PSS370 (red line), PSS485 (blue line) in D2O/DMSO-d6 ...
Figure 4: ITC titration of LecA with E- (up) and Z-isomers (bottom) of compounds 1–5 in Tris buffer containin...
Figure 5: (A) Enthalpy–entropy compensation plot of compounds 1–5 from ITC analysis. The dotted green line re...
Beilstein J. Org. Chem. 2024, 20, 1207–1212, doi:10.3762/bjoc.20.103
Graphical Abstract
Figure 1: Nitrogen-doped nanocarbons. (a) Schematic illustration of pyridinic nitrogen atoms installed at the...
Scheme 1: Syntheses of 3a and 3b.
Figure 2: Photophysical properties of 3a and 3b. (a) UV–vis spectrum of 3a in CHCl3. (b) UV–vis spectrum of 3b...
Figure 3: Crystal structures of 3a and 3b. (a) Molecular structures. Biaryl dihedral angles (ω) are shown. (b...
Figure 4: X-ray charge density analyses of 3a and [6]CMP. (a) Deformation map (Fo – Fc) of a pyridine ring in ...
Figure 5: Response towards acid treatment with nitrogen-doped CMPs. (a) Absorption spectra of 3a (CHCl3, 2.3 ...
Beilstein J. Org. Chem. 2022, 18, 660–668, doi:10.3762/bjoc.18.67
Graphical Abstract
Scheme 1: Synthesis of cyclochexene oxide via epoxidation with air in the presence of isobutyraldehyde.
Figure 1: Epoxidation of cyclohexene with air bubbling in batch at various temperature.
Figure 2: Schematic diagram (a) and photo (b) of the flow reactor used for cyclohexene epoxidation with air. ...
Figure 3: Investigation of reaction temperature in flow epoxidation of cyclohexene at residence time of 0.35 ...
Figure 4: Investigation of residence time in flow epoxidation of cyclohexene at 100 °C.
Scheme 2: Plausible reaction pathway of the epoxidation of cyclohexene with air in the flow system.
Figure 5: Continuous production of cyclohexene oxide.
Figure 6: Effect of concentration of cyclohexene and eqivalent of aldehyde.
Beilstein J. Org. Chem. 2021, 17, 1181–1312, doi:10.3762/bjoc.17.90
Graphical Abstract
Figure 1: Representative shares of the global F&F market (2018) segmented on their applications [1].
Figure 2: General structure of an international fragrance company [2].
Figure 3: The Michael Edwards fragrance wheel.
Figure 4: Examples of oriental (1–3), woody (4–7), fresh (8–10), and floral (11 and 12) notes.
Figure 5: A basic depiction of batch vs flow.
Scheme 1: Examples of reactions for which flow processing outperforms batch.
Scheme 2: Some industrially important aldol-based transformations.
Scheme 3: Biphasic continuous aldol reactions of acetone and various aldehydes.
Scheme 4: Aldol synthesis of 43 in flow using LiHMDS as the base.
Scheme 5: A semi-continuous synthesis of doravirine (49) involving a key aldol reaction.
Scheme 6: Enantioselective aldol reaction using 5-(pyrrolidin-2-yl)tetrazole (51) as catalyst in a microreact...
Scheme 7: Gröger's example of asymmetric aldol reaction in aqueous media.
Figure 6: Immobilised reagent column reactor types.
Scheme 8: Photoinduced thiol–ene coupling preparation of silica-supported 5-(pyrrolidin-2-yl)tetrazole 63 and...
Scheme 9: Continuous-flow approach for enantioselective aldol reactions using the supported catalyst 67.
Scheme 10: Ötvös’ employment of a solid-supported peptide aldol catalyst in flow.
Scheme 11: The use of proline tetrazole packed in a column for aldol reaction between cyclohexanone (65) and 2...
Scheme 12: Schematic diagram of an aminosilane-grafted Si-Zr-Ti/PAI-HF reactor for continuous-flow aldol and n...
Scheme 13: Continuous-flow condensation for the synthesis of the intermediate 76 to nabumetone (77) and Microi...
Scheme 14: Synthesis of ψ-Ionone (80) in continuous-flow via aldol condensation between citral (79) and aceton...
Scheme 15: Synthesis of β-methyl-ionones (83) from citral (79) in flow. The steps are separately described, an...
Scheme 16: Continuous-flow synthesis of 85 from 84 described by Gavriilidis et al.
Scheme 17: Continuous-flow scCO2 apparatus for the synthesis of 2-methylpentanal (87) and the self-condensed u...
Scheme 18: Chen’s two-step flow synthesis of coumarin (90).
Scheme 19: Pechmann condensation for the synthesis of 7-hydroxyxcoumarin (93) in flow. The setup extended to c...
Scheme 20: Synthesis of the dihydrojasmonate 35 exploiting nitro derivative proposed by Ballini et al.
Scheme 21: Silica-supported amines as heterogeneous catalyst for nitroaldol condensation in flow.
Scheme 22: Flow apparatus for the nitroaldol condensation of p-hydroxybenzaldehyde (102) to nitrostyrene 103 a...
Scheme 23: Nitroaldol reaction of 64 to 105 employing a quaternary ammonium functionalised PANF.
Scheme 24: Enantioselective nitroaldol condensation for the synthesis of 108 under flow conditions.
Scheme 25: Enatioselective synthesis of 1,2-aminoalcohol 110 via a copper-catalysed nitroaldol condensation.
Scheme 26: Examples of Knoevenagel condensations applied for fragrance components.
Scheme 27: Flow apparatus for Knoevenagel condensation described in 1989 by Venturello et al.
Scheme 28: Knoevenagel reaction using a coated multichannel membrane microreactor.
Scheme 29: Continuous-flow apparatus for Knoevenagel condensation employing sugar cane bagasse as support deve...
Scheme 30: Knoevenagel reaction for the synthesis of 131–135 in flow using an amine-functionalised silica gel. ...
Scheme 31: Continuous-flow synthesis of compound 137, a key intermediate for the synthesis of pregabalin (138)...
Scheme 32: Continuous solvent-free apparatus applied for the synthesis of compounds 140–143 using a TSE. Throu...
Scheme 33: Lewis et al. developed a spinning disc reactor for Darzens condensation of 144 and a ketone to furn...
Scheme 34: Some key industrial applications of conjugate additions in the F&F industry.
Scheme 35: Continuous-flow synthesis of 4-(2-hydroxyethyl)thiomorpholine 1,1-dioxide (156) via double conjugat...
Scheme 36: Continuous-flow system for Michael addition using CsF on alumina as the catalyst.
Scheme 37: Calcium chloride-catalysed asymmetric Michael addition using an immobilised chiral ligand.
Scheme 38: Continuous multistep synthesis for the preparation of (R)-rolipram (173). Si-NH2: primary amine-fun...
Scheme 39: Continuous-flow Michael addition using ion exchange resin Amberlyst® A26.
Scheme 40: Preparation of the heterogeneous catalyst 181 developed by Paixão et al. exploiting Ugi multicompon...
Scheme 41: Continuous-flow system developed by the Paixão’s group for the preparation of Michael asymmetric ad...
Scheme 42: Continuous-flow synthesis of nitroaldols catalysed by supported catalyst 184 developed by Wennemers...
Scheme 43: Heterogenous polystyrene-supported catalysts developed by Pericàs and co-workers.
Scheme 44: PANF-supported pyrrolidine catalyst for the conjugate addition of cyclohexanone (65) and trans-β-ni...
Scheme 45: Synthesis of (−)-paroxetine precursor 195 developed by Ötvös, Pericàs, and Kappe.
Scheme 46: Continuous-flow approach for the 5-step synthesis of (−)-oseltamivir (201) as devised by Hayashi an...
Scheme 47: Continuous-flow enzyme-catalysed Michael addition.
Scheme 48: Continuous-flow copper-catalysed 1,4 conjugate addition of Grignard reagents to enones. Reprinted w...
Scheme 49: A collection of commonly encountered hydrogenation reactions.
Figure 7: The ThalesNano H-Cube® continuous-flow hydrogenator.
Scheme 50: Chemoselective reduction of an α,β-unsaturated ketone using the H-Cube® reactor.
Scheme 51: Incorporation of Lindlar’s catalyst into the H-Cube® reactor for the reduction of an alkyne.
Scheme 52: Continuous-flow semi-hydrogenation of alkyne 208 to 209 using SACs with H-Cube® system.
Figure 8: The standard setups for tube-in-tube gas–liquid reactor units.
Scheme 53: Homogeneous hydrogenation of olefins using a tube-in-tube reactor setup.
Scheme 54: Recyclable heterogeneous flow hydrogenation system.
Scheme 55: Leadbeater’s reverse tube-in-tube hydrogenation system for olefin reductions.
Scheme 56: a) Hydrogenation using a Pd-immobilised microchannel reactor (MCR) and b) a representation of the i...
Scheme 57: Hydrogenation of alkyne 238 exploiting segmented flow in a Pd-immobilised capillary reactor.
Scheme 58: Continuous hydrogenation system for the preparation of cyrene (241) from (−)-levoglucosenone (240).
Scheme 59: Continuous hydrogenation system based on CSMs developed by Hornung et al.
Scheme 60: Chemoselective reduction of carbonyls (ketones over aldehydes) in flow.
Scheme 61: Continuous system for the semi-hydrogenation of 256 and 258, developed by Galarneau et al.
Scheme 62: Continuous synthesis of biodiesel fuel 261 from lignin-derived furfural acetone (260).
Scheme 63: Continuous synthesis of γ-valerolacetone (263) via CTH developed by Pineda et al.
Scheme 64: Continuous hydrogenation of lignin-derived biomass (products 265, 266, and 267) using a sustainable...
Scheme 65: Ru/C or Rh/C-catalysed hydrogenation of arene in flow as developed by Sajiki et al.
Scheme 66: Polysilane-immobilized Rh–Pt-catalysed hydrogenation of arenes in flow by Kobayashi et al.
Scheme 67: High-pressure in-line mixing of H2 for the asymmetric reduction of 278 at pilot scale with a 73 L p...
Figure 9: Picture of the PFR employed at Eli Lilly & Co. for the continuous hydrogenation of 278 [287]. Reprinted ...
Scheme 68: Continuous-flow asymmetric hydrogenation using Oppolzer's sultam 280 as chiral auxiliary.
Scheme 69: Some examples of industrially important oxidation reactions in the F&F industry. CFL: compact fluor...
Scheme 70: Gold-catalysed heterogeneous oxidation of alcohols in flow.
Scheme 71: Uozumi’s ARP-Pt flow oxidation protocol.
Scheme 72: High-throughput screening of aldehyde oxidation in flow using an in-line GC.
Scheme 73: Permanganate-mediated Nef oxidation of nitroalkanes in flow with the use of in-line sonication to p...
Scheme 74: Continuous-flow aerobic anti-Markovnikov Wacker oxidation.
Scheme 75: Continuous-flow oxidation of 2-benzylpyridine (312) using air as the oxidant.
Scheme 76: Continuous-flow photo-oxygenation of monoterpenes.
Scheme 77: A tubular reactor design for flow photo-oxygenation.
Scheme 78: Glucose oxidase (GOx)-mediated continuous oxidation of glucose using compressed air and the FFMR re...
Scheme 79: Schematic continuous-flow sodium hypochlorite/TEMPO oxidation of alcohols.
Scheme 80: Oxidation using immobilised TEMPO (344) was developed by McQuade et al.
Scheme 81: General protocol for the bleach/catalytic TBAB oxidation of aldehydes and alcohols.
Scheme 82: Continuous-flow PTC-assisted oxidation using hydrogen peroxide. The process was easily scaled up by...
Scheme 83: Continuous-flow epoxidation of cyclohexene (348) and in situ preparation of m-CPBA.
Scheme 84: Continuous-flow epoxidation using DMDO as oxidant.
Scheme 85: Mukayama aerobic epoxidation optimised in flow mode by the Favre-Réguillon group.
Scheme 86: Continuous-flow asymmetric epoxidation of derivatives of 359 exploiting a biomimetic iron catalyst.
Scheme 87: Continuous-flow enzymatic epoxidation of alkenes developed by Watts et al.
Scheme 88: Engineered multichannel microreactor for continuous-flow ozonolysis of 366.
Scheme 89: Continuous-flow synthesis of the vitamin D precursor 368 using multichannel microreactors. MFC: mas...
Scheme 90: Continuous ozonolysis setup used by Kappe et al. for the synthesis of various substrates employing ...
Scheme 91: Continuous-flow apparatus for ozonolysis as developed by Ley et al.
Scheme 92: Continuous-flow ozonolysis for synthesis of vanillin (2) using a film-shear flow reactor.
Scheme 93: Examples of preparative methods for ajoene (386) and allicin (388).
Scheme 94: Continuous-flow oxidation of thioanisole (389) using styrene-based polymer-supported peroxytungstat...
Scheme 95: Continuous oxidation of thiosulfinates using Oxone®-packed reactor.
Scheme 96: Continuous-flow electrochemical oxidation of thioethers.
Scheme 97: Continuous-flow oxidation of 400 to cinnamophenone (235).
Scheme 98: Continuous-flow synthesis of dehydrated material 401 via oxidation of methyl dihydrojasmonate (33).
Scheme 99: Some industrially important transformations involving Grignard reagents.
Scheme 100: Grachev et al. apparatus for continuous preparation of Grignard reagents.
Scheme 101: Example of fluidized Mg bed reactor with NMR spectrometer as on-line monitoring system.
Scheme 102: Continuous-flow synthesis of Grignard reagents and subsequent quenching reaction.
Figure 10: Membrane-based, liquid–liquid separator with integrated pressure control [52]. Adapted with permission ...
Scheme 103: Continuous-flow synthesis of 458, an intermediate to fluconazole (459).
Scheme 104: Continuous-flow synthesis of ketones starting from benzoyl chlorides.
Scheme 105: A Grignard alkylation combining CSTR and PFR technologies with in-line infrared reaction monitoring....
Scheme 106: Continuous-flow preparation of 469 from Grignard addition of methylmagnesium bromide.
Scheme 107: Continuous-flow synthesis of Grignard reagents 471.
Scheme 108: Preparation of the Grignard reagent 471 using CSTR and the continuous process for synthesis of the ...
Scheme 109: Continuous process for carboxylation of Grignard reagents in flow using tube-in-tube technology.
Scheme 110: Continuous synthesis of propargylic alcohols via ethynyl-Grignard reagent.
Scheme 111: Silica-supported catalysed enantioselective arylation of aldehydes using Grignard reagents in flow ...
Scheme 112: Acid-catalysed rearrangement of citral and dehydrolinalool derivatives.
Scheme 113: Continuous stilbene isomerisation with continuous recycling of photoredox catalyst.
Scheme 114: Continuous-flow synthesis of compound 494 as developed by Ley et al.
Scheme 115: Selected industrial applications of DA reaction.
Scheme 116: Multistep flow synthesis of the spirocyclic structure 505 via employing DA cycloaddition.
Scheme 117: Continuous-flow DA reaction developed in a plater flow reactor for the preparation of the adduct 508...
Scheme 118: Continuous-flow DA reaction using a silica-supported imidazolidinone organocatalyst.
Scheme 119: Batch vs flow for the DA reaction of (cyclohexa-1,5-dien-1-yloxy)trimethylsilane (513) with acrylon...
Scheme 120: Continuous-flow DA reaction between 510 and 515 using a shell-core droplet system.
Scheme 121: Continuous-flow synthesis of bicyclic systems from benzyne precursors.
Scheme 122: Continuous-flow synthesis of bicyclic scaffolds 527 and 528 for further development of potential ph...
Scheme 123: Continuous-flow inverse-electron hetero-DA reaction to pyridine derivatives such as 531.
Scheme 124: Comparison between batch and flow for the synthesis of pyrimidinones 532–536 via retro-DA reaction ...
Scheme 125: Continuous-flow coupled with ultrasonic system for preparation of ʟ-ascorbic acid derivatives 539 d...
Scheme 126: Two-step continuous-flow synthesis of triazole 543.
Scheme 127: Continuous-flow preparation of triazoles via CuAAC employing 546-based heterogeneous catalyst.
Scheme 128: Continuous-flow synthesis of compounds 558 through A3-coupling and 560 via AgAAC both employing the...
Scheme 129: Continuous-flow photoinduced [2 + 2] cycloaddition for the preparation of bicyclic derivatives of 5...
Scheme 130: Continuous-flow [2 + 2] and [5 + 2] cycloaddition on large scale employing a flow reactor developed...
Scheme 131: Continuous-flow preparation of the tricyclic structures 573 and 574 starting from pyrrole 570 via [...
Scheme 132: Continuous-flow [2 + 2] photocyclization of cinnamates.
Scheme 133: Continuous-flow preparation of cyclobutane 580 on a 5-plates photoreactor.
Scheme 134: Continuous-flow [2 + 2] photocycloaddition under white LED lamp using heterogeneous PCN as photocat...
Figure 11: Picture of the parallel tube flow reactor (PTFR) "The Firefly" developed by Booker-Milburn et al. a...
Scheme 135: Continuous-flow acid-catalysed [2 + 2] cycloaddition between silyl enol ethers and acrylic esters.
Scheme 136: Continuous synthesis of lactam 602 using glass column reactors.
Scheme 137: In situ generation of ketenes for the Staudinger lactam synthesis developed by Ley and Hafner.
Scheme 138: Application of [2 + 2 + 2] cycloadditions in flow employed by Ley et al.
Scheme 139: Examples of FC reactions applied in F&F industry.
Scheme 140: Continuous-flow synthesis of ibuprofen developed by McQuade et al.
Scheme 141: The FC acylation step of Jamison’s three-step ibuprofen synthesis.
Scheme 142: Synthesis of naphthalene derivative 629 via FC acylation in microreactors.
Scheme 143: Flow system for rapid screening of catalysts and reaction conditions developed by Weber et al.
Scheme 144: Continuous-flow system developed by Buorne, Muller et al. for DSD optimisation of the FC acylation ...
Scheme 145: Continuous-flow FC acylation of alkynes to yield β-chlorovinyl ketones such as 638.
Scheme 146: Continuous-flow synthesis of tonalide (619) developed by Wang et al.
Scheme 147: Continuous-flow preparation of acylated arene such as 290 employing Zr4+-β-zeolite developed by Kob...
Scheme 148: Flow system applied on an Aza-FC reaction catalysed by the thiourea catalyst 648.
Scheme 149: Continuous hydroformylation in scCO2.
Scheme 150: Two-step flow synthesis of aldehyde 655 through a sequential Heck reaction and subsequent hydroform...
Scheme 151: Single-droplet (above) and continuous (below) flow reactors developed by Abolhasani et al. for the ...
Scheme 152: Continuous hydroformylation of 1-dodecene (655) using a PFR-CSTR system developed by Sundmacher et ...
Scheme 153: Continuous-flow synthesis of the aldehyde 660 developed by Eli Lilly & Co. [32]. Adapted with permissio...
Scheme 154: Continuous asymmetric hydroformylation employing heterogenous catalst supported on carbon-based sup...
Scheme 155: Examples of acetylation in F&F industry: synthesis of bornyl (S,R,S-664) and isobornyl (S,S,S-664) ...
Scheme 156: Continuous-flow preparation of bornyl acetate (S,R,S-664) employing the oscillating flow reactor.
Scheme 157: Continuous-flow synthesis of geranyl acetate (666) from acetylation of geraniol (343) developed by ...
Scheme 158: 12-Ttungstosilicic acid-supported silica monolith-catalysed acetylation in flow.
Scheme 159: Continuous-flow preparation of cyclopentenone 676.
Scheme 160: Two-stage synthesis of coumarin (90) via acetylation of salicylaldehyde (88).
Scheme 161: Intensification process for acetylation of 5-methoxytryptamine (677) to melatonin (678) developed b...
Scheme 162: Examples of macrocyclic musky odorants both natural (679–681) and synthetic (682 and 683).
Scheme 163: Flow setup combined with microwave for the synthesis of macrocycle 686 via RCM.
Scheme 164: Continuous synthesis of 2,5-dihydro-1H-pyrroles via ring-closing metathesis.
Scheme 165: Continuous-flow metathesis of 485 developed by Leadbeater et al.
Figure 12: Comparison between RCM performed using different routes for the preparation of 696. On the left the...
Scheme 166: Continuous-flow RCM of 697 employed the solid-supported catalyst 698 developed by Grela, Kirschning...
Scheme 167: Continuous-flow RORCM of cyclooctene employing the silica-absorbed catalyst 700.
Scheme 168: Continuous-flow self-metathesis of methyl oleate (703) employing SILP catalyst 704.
Scheme 169: Flow apparatus for the RCM of 697 using a nanofiltration membrane for the recovery and reuse of the...
Scheme 170: Comparison of loadings between RCMs performed with different routes for the synthesis of 709.
Beilstein J. Org. Chem. 2020, 16, 628–637, doi:10.3762/bjoc.16.59
Graphical Abstract
Figure 1: Chemical structures of the target diazine-based surrogates for the central core of panobinostat.
Figure 2: Docking pose for panobinostat and panobinostat derivatives in the HDAC8 receptor. (a) Overlay of al...
Figure 3: General building blocks for the visualized targets.
Scheme 1: Reaction conditions: a) MeOH, H2SO4 (5 drops), MS 4 Å (2 pieces), 68 °C, 8 h, 81%; b) DIBAL-H (1.2 ...
Scheme 2: Reaction conditions: a) boronic acid 15 (1.3 equiv), PdCl2(PPh3)2 (0.1 equiv), dioxane/H2O (3:1), Na...
Scheme 3: Reaction conditions: a) 5-bromo-2-chloropyrimidine (1 equiv), ethyl formate (1.5 equiv), THF (20 mL...
Scheme 4: Reaction conditions: a) boronic acid 15 (1.3 equiv), PdCl2(PPh3)2 (0.1 equiv), dioxane/H2O (8:2, Na2...
Beilstein J. Org. Chem. 2019, 15, 2830–2839, doi:10.3762/bjoc.15.276
Graphical Abstract
Figure 1: Pharmacologically relevant furoindoles.
Scheme 1: Synthesis of benzo[4,5]furo[3,2-b]indoles 5a–j. Conditions: (i) 1.2 equiv 2-bromophenylboronic acid...
Figure 2: Ortep of 5c (propability of ellipsoids: 45%).
Figure 3: Diindolofurans 6a–e.
Figure 4: Illustration of binding poses of selected inhibitors for the ENPP1 homology model: (a): suramin, (b...
Figure 5: 3D poses of docked selected inhibitors inside homology model of ENPP3. (a): suramin, (b): 5e, (c): ...
Beilstein J. Org. Chem. 2019, 15, 2753–2764, doi:10.3762/bjoc.15.266
Graphical Abstract
Figure 1: a) Tetra ortho-substituted azobenzenes represent a significant advance in terms of Z-isomer stabili...
Figure 2: Minimum-energy geometry calculated for a) the Z-isomer ground state and b) the transition states wi...
Figure 3: Noncovalent index (NCI) surfaces calculated for representative pyrrolidine-based ortho-substituted ...
Figure 4: Noncovalent index (NCI) surfaces and θ dihedral angles (in red) calculated for the minimum-energy g...
Figure 5: Description of the lowest-lying n–π* excitation for the Z-isomers of halogenated 4pzH-F2 and 4pzH-C...
Figure 6: Description of the lowest-lying n–π* excitation for the E-isomers of halogenated 4pzH-F2 and 4pzH-C...
Figure 7: X-ray structures of 4pzMe-F2 (left), 4pzH-F2 (middle) and 4pzMe-OMe2 (right).
Figure 8: Experimental UV–vis spectra of 4pzMe-F2, 4pzMe-Cl2, 4pzMe-OMe2 and 4pzH-F2 in MeCN at 25 µM.
Beilstein J. Org. Chem. 2019, 15, 106–129, doi:10.3762/bjoc.15.12
Graphical Abstract
Figure 1: Left: The graphs of an interaction potential Vint composed of an attractive component Vatt and a re...
Figure 2: From left to right: An external pulling force acting on the system in its equilibrium structure inc...
Figure 3: Potential functions (thin lines) and the first derivatives (thick lines). Left: For constant ΔV the...
Figure 4: Left: The disk covering the atoms of molecule B seen by an atom in molecule A expands with increasi...
Figure 5: Demonstration of the contact zone and the reduced contact zone of an adsorbate/adsorbent complex wi...
Figure 6: The contact zone of an (8.0)-CNT/tetracene complex. The bold black lines in the traverse section re...
Figure 7: The separation of tetracene from graphene. Top row: Mode S1 (left), mode S2 (right). Bottom row: mo...
Figure 8: The slope functions for the separation of tetracene from graphene for the four separation modes. Re...
Figure 9: Boiling points of straight-chain primary alcohols, straight-chain primary amines and straight-chain...
Beilstein J. Org. Chem. 2018, 14, 1491–1497, doi:10.3762/bjoc.14.126
Graphical Abstract
Figure 1: Compounds containing a phenoxazine moiety.
Scheme 1: Reported syntheses of phenoxazine derivatives.
Scheme 2: Retrosynthesis of phenoxazine.
Scheme 3: Synthesis of iodonium salt 5a.
Scheme 4: Synthesis of iodonium salt 7.
Scheme 5: O-Arylation via route B.
Scheme 6: a) Cyclization of diaryl ether 3. b) Attempted one pot-synthesis of 2. aBased on recovered 3.
Scheme 7: Formal synthesis of phenoxazine (1). aBased on recovered 3.
Beilstein J. Org. Chem. 2018, 14, 1263–1280, doi:10.3762/bjoc.14.108
Graphical Abstract
Scheme 1: Overview of different types of iodane-based group-transfer reactions and their atom economy based o...
Scheme 2: (a) Structure of diaryliodonium salts 1. (b) Diarylation of a suitable substrate A with one equival...
Scheme 3: Synthesis of biphenyls 3 and 3’ with symmetrical diaryliodonium salts 1.
Scheme 4: Synthesis of diaryl thioethers 5.
Scheme 5: Synthesis of two distinct S-aryl dithiocarbamates 7 and 7’ from one equivalent of diaryliodonium sa...
Scheme 6: Synthesis of substituted isoindolin-1-ones 9 from 2-formylbenzonitrile 8 and the postulated reactio...
Scheme 7: Domino C-/N-arylation of indoles 10.
Scheme 8: Domino modification of N-heterocycles 12 via in situ-generated directing groups.
Scheme 9: Synthesis of triarylamines 17 through a double arylation of anilines.
Scheme 10: Selective conversion of novel aryl(imidazolyl)iodonium salts 1b to 1,5-disubstituted imidazoles 18.
Scheme 11: Selected examples for the application of cyclic diaryliodonium salts 19.
Scheme 12: Tandem oxidation–arylation sequence with (dicarboxyiodo)benzenes 20.
Scheme 13: Oxidative α-arylation via the transfer of an intact 2-iodoaryl group.
Scheme 14: Tandem ortho-iodination/O-arylation cascade with PIDA derivatives 20b.
Scheme 15: Synthesis of meta-N,N-diarylaminophenols 28 and the postulated mechanism.
Scheme 16: (Dicarboxyiodo)benzene-mediated metal-catalysed C–H amination and arylation.
Scheme 17: Postulated mechanism for the amination–arylation sequence.
Scheme 18: Auto-amination and cross-coupling of PIDA derivatives 20c.
Scheme 19: Tandem C(sp3)–H olefination/C(sp2)–H arylation.
Scheme 20: Atom efficient functionalisations with benziodoxolones 36.
Scheme 21: Atom-efficient synthesis of furans 39 from benziodoxolones 36a and their further derivatisations.
Scheme 22: Oxyalkynylation of diazo compounds 42.
Scheme 23: Enantioselective oxyalkynylation of diazo compounds 42’.
Scheme 24: Iron-catalysed oxyazidation of enamides 45.
Beilstein J. Org. Chem. 2018, 14, 1016–1020, doi:10.3762/bjoc.14.87
Graphical Abstract
Scheme 1: Representative examples of benziodoxoles and benziodazoles.
Scheme 2: Preparation of bicyclic benziodazole 7a.
Figure 1: X-ray crystal structure of compound 7a. Ellipsoids are drawn to the 50% probability level. Selected...
Scheme 3: Benziodadiazole 7a mediated oxidatively assisted esterification and amidation reactions.
Beilstein J. Org. Chem. 2018, 14, 364–372, doi:10.3762/bjoc.14.24
Graphical Abstract
Figure 1: Compounds used for the biological study.
Figure 2: Compounds 1–4 induced cell death in U937 cells. Briefly, U937 cells (1 × 104 cells/mL) were incubat...
Scheme 1: Synthesis of pentafluoro-(2-iodophenyl)-λ6-sulfane (7).
Scheme 2: Synthesis of unsymmetrical ortho-SF5 diaryliodonium salts 3p, 4b, 5a and 6a.
Figure 3: X-ray crystallographic structure of 3p drawn at 50% probability (CCDC 1573953).
Figure 4: Ortho-SF5 phenyl iodonium salts 3p and 5a and their structural components 7 and 9 induced cell deat...
Figure 5: 3k, 3m and 3p induced cell death in AGLCL, a human normal B cell line. Briefly, AGLCL cells (1 × 104...
Beilstein J. Org. Chem. 2017, 13, 995–1007, doi:10.3762/bjoc.13.99
Graphical Abstract
Figure 1: Chemical structure of PC-C18pPhC18-PC.
Scheme 1: Synthesis of PC-C18pPhC18-PC; TBAF: tetra-n-butylammonium fluoride, TEA: triethylamine, rt: room te...
Figure 2: DSC curves for PC-C18pPhC18-PC (c = 1 mg mL−1 in H2O, solid lines, heating: red, cooling: blue). FT...
Figure 3: TEM image of an aqueous suspension (c = 0.05 mg mL−1) of PC-C18pPhC18-PC. The samples were prepared...
Figure 4: SANS data of a suspension of PC-C18pPhC18-PC (c = 1 mg mL−1 in D2O, scattered data) with IFT analys...
Figure 5: DSC heating (left-hand column) and cooling (right-hand column) scans of different PC-C18pPhC18-PC:p...
Figure 6: TEM images of aqueous suspensions (c = 60 µM or c = 30 µM for C) of PC-C18pPhC18-PC/phospholipid mi...
Figure 7: FTIR spectroscopic data (symmetric CH2 stretching vibration: red squares, right axis; symmetric CD2...
Figure 8: (A) SAXS diffractograms of an equimolar mixture of PC-C18pPhC18-PC/DPPC (c = 10 mg mL−1, scattered ...
Beilstein J. Org. Chem. 2016, 12, 1410–1420, doi:10.3762/bjoc.12.135
Graphical Abstract
Figure 1: The four coordination geometries for d10 polyene-ML2 complexes along with their hapto numbers and e...
Figure 2: The important valence orbitals of a d10 ML2 group, 5–7, along with the computed structures of Pt(PH3...
Figure 3: The empty degenerate set of π orbitals in the cyclopropenium cation is shown on the left side. On t...
Figure 4: Two unoccupied MOs for Cp+ are shown on the left side. The two stationary points for Cp–Pt(dpe)+ ar...
Figure 5: The half-filled degenerate π orbitals in cyclobutadiene. The computed ground state (15) and transit...
Figure 6: The ground and transition state for ring whizzing in F6C6–Pt(dpe), 17 and 20, respectively. The dom...
Figure 7: The LUMO, 23, and HOMO, 27, in 6-radialene. The optimized η2 ground states are shown in 24 and 25 w...
Figure 8: Two representations for the half-filled e2u set of π orbitals in cyclooctatetraene.
Figure 9: The stationary points found on the potential energy surface of C8F8–Pt(dpe). For clarity the groups...
Figure 10: The two important bonding interactions for transition state 31 are drawn in 33 and 34.
Figure 11: Three other coordination geometries that did not lead to new stationary points are shown in 35–37.
Figure 12: The LUMO and LUMO+1 shown in 38 and 39, respectively. The four stationary points found for pentalen...
Figure 13: The LUMO of the phenalenium cation is given in 44. The structures of the three stationary points fo...
Figure 14: A top view of two stationary points found for F8C10–Pt(dpe); 48 is the ground state and 50, represe...
Figure 15: At top view of the η4, 52, and η4, 54, transition states along with the η2, 53, intermediate.
Beilstein J. Org. Chem. 2016, 12, 571–588, doi:10.3762/bjoc.12.56
Graphical Abstract
Figure 1: Selected monocyclic and monobenzo α-pyrone structures.
Figure 2: The basic core structure of dibenzo-α-pyrones.
Figure 3: Selected dibenzo-α-pyrones.
Figure 4: Structure of ellagic acid and of the urolithins, the latter metabolized from ellagic acid by intest...
Figure 5: Structure of murayalactone, the only dibenzo-α-pyrone described from bacteria.
Figure 6: Structures of the 6-pentyl-2-pyrone (29) and of trichopyrone (30). Only 29 showed antifungal activi...
Figure 7: Selected monocyclic α-pyrones.
Figure 8: Structures of the gibepyrones A–F.
Figure 9: Structures of the phomenins A and B.
Figure 10: Structures of monocyclic α-pyrones showing pheromone (47) and antitumor activity (48), respectively....
Figure 11: Structures of 6-alkyl (alkoxy or alkylthio)-4-aryl-3-(4-methanesulfonylphenyl)pyrones.
Figure 12: Structures of kavalactones.
Figure 13: Strutures of germicins.
Figure 14: Structures of the pseudopyronines.
Figure 15: The structures of the monobenzo-α-pyrone anticoagulant drugs warfarin and phenprocoumon.
Figure 16: Structures of selected monobenzo-α-pyrones.
Figure 17: Hypothetical pathway of 29 generation from linoleic acid [34].
Figure 18: Proposed biosynthetic pathway of alternariol (modified from [77]). Malonyl-CoA building blocks are appl...
Figure 19: Structures of phenylnannolones and of enterocin, both biosynthesized via polyketide synthase system...
Figure 20: Pyrone ring formation. Examples for the three types of PKS systems are shown in A–C. In D the mecha...
Figure 21: Structures of csypyrones.
Figure 22: Schematic drawing of the T-shaped catalytic cavities of the related enzymes CorB and MxnB. The two ...
Figure 23: Stereo representation of the CorB binding situation (modified from [89]). The substrate mimic (dark vio...
Figure 24: Proposed mechanism for the CsyB enzymatic reaction. A) Coupling reaction of the β-keto fatty acyl i...
Figure 25: Proposed biosynthesis of photopyrone D (37) by the enzyme PpyS from P. luminescens (modified from [63])...
Beilstein J. Org. Chem. 2015, 11, 184–191, doi:10.3762/bjoc.11.19
Graphical Abstract
Figure 1: Acyl phosphorus compounds.
Scheme 1: Synthesis of a dinucleoside acylphosphonate (3b) and a formate diester (1a).
Scheme 2: Reaction of an H-phosphonodiamidite with acid chlorides.
Figure 2: ORTEP [52] drawing of 9. Selected distances (Å) and angles (°): P–N1 1.687(1), P–N2 1.679(1), P–C1 1.87...
Scheme 3: Synthesis of dinucleosides.
Scheme 4: Calculated phosphine, acylphosphine, phosphite, and acylphosphonite inversion barriers.
Beilstein J. Org. Chem. 2014, 10, 2704–2714, doi:10.3762/bjoc.10.285
Graphical Abstract
Figure 1: The structures of the star-shaped oligofluorenes with BODIPY cores, Y-Bn (n = 1–4) and T-Bn (n = 1–...
Scheme 1: Synthesis of the Y-Bn (n = 1–4) series.
Scheme 2: Synthesis of the T-Bn (n = 1–4) series.
Figure 2: The samples of oligofluorene BODIPY solutions in toluene under ambient light (left) and UV illumina...
Figure 3: The normalised absorption (solid lines) and emission (dash lines) spectra of Y-Bn (n = 1–4) (left p...
Figure 4: Optimised structures of T-B1 (left) and Y-B1 (right).
Figure 5: HOMO−1 (bottom, left), HOMO (bottom, right), LUMO (top, left) and LUMO+1 (top, right) of Y-B1.
Figure 6: HOMO−1 (bottom, left), HOMO (bottom, right), LUMO (top, left) and LUMO+1 (top, right) of T-B1.
Beilstein J. Org. Chem. 2014, 10, 307–315, doi:10.3762/bjoc.10.28
Graphical Abstract
Scheme 1: 1,1,3,3-Tetramethylindane derivatives are preferable.
Scheme 2: “Hydrolysis” of 6, and the KOR/dimsyl-K (11) system.
Scheme 3: Proposed carbenoid pathway from 6 to acid 10 and dimethyl sulfide (Me2S) in DMSO as the solvent.
Scheme 4: Proposed pathway to the main side-product 23 formed by nucleophilic addition of 11 to C-2 of 6.
Scheme 5: Possible course of the carbenoid chain reaction of 12 with DMSO and the α,α-dichloroalkene 6.
Scheme 6: Synthesis of the one-sidedly overcrowded descendants 38, 39, and 42.
Beilstein J. Org. Chem. 2013, 9, 2715–2750, doi:10.3762/bjoc.9.308
Graphical Abstract
Scheme 1: Exemplary 1,3-dipolar cycloaddition of phenylacetylene with phenyl azide [6].
Scheme 2: CuAAC reaction of benzyl azide with (prop-2-yn-1-yloxy)benzene [12].
Scheme 3: Bioconjugation reaction of capsid-bound azide groups with alkynyl-functionalized dye molecules (cow...
Figure 1: Tris(triazolylmethyl)amine ligands for CuAAC applications in bioorganic chemistry: TBTA = tris[(1-b...
Figure 2: Derivatives of 2,2’-bipyridine and 1,10-phenanthroline, commonly used ligands in CuAAC reactions un...
Scheme 4: CuAAC reaction with copper(II) precursor salt and rate-accelerating monodentate phosphoramidite lig...
Scheme 5: Synthesis of 1-(adamant-1-yl)-1H-1,2,3-triazol-4-ylcarbonyl-Phe-Gly-OH by solid-supported Click cat...
Scheme 6: CuAAC reaction with re-usable copper(I)-tren catalyst [129].
Scheme 7: CuAAC test reaction with chlorido[tris(1-benzyl-1H-1,2,3-triazol-4-yl)methanol-κ3N3]copper(I) and a...
Scheme 8: CuAAC model reaction with [Cu2(μ-TBTA-κ4N2,N3,N3’,N3’’)2][BF4]2 [131].
Scheme 9: Application of a (2-aminoarenethiolato)copper(I) complex as homogeneous catalyst for the CuAAC test...
Scheme 10: Application of [CuBr(PPh3)3] as homogeneous catalyst for the CuAAC test reaction of benzyl azide wi...
Figure 3: Phosphinite and phosphonite copper(I) complexes presented by Díez-González [144].
Scheme 11: Effect of additives on the CuAAC test reaction with [(SIMes)CuCl] [149].
Scheme 12: Initiation of the catalytic cycle by formation of the copper acetylide intermediate from [(ICy)2Cu]...
Scheme 13: Early mechanistic proposal by Sharpless [12,42].
Scheme 14: Chemoselective synthesis of a 5-iodo-1,4-disubstituted 1,2,3-triazole [156].
Scheme 15: Mechanistic proposals for the copper-catalyzed azide–iodoalkyne cycloaddition [156].
Scheme 16: 1,3-Dipolar cycloaddition of 3-hexyne catalyzed by [(SIMes)CuBr] [146].
Scheme 17: Mechanistic picture for the cycloaddition of internal alkynes catalyzed by NHC-copper(I) complexes ...
Scheme 18: Catalytic cycle of the CuAAC reaction on the basis of the proposed mechanistic scheme by Fokin and ...
Figure 4: Schematic representation of the single crystal X-ray structures of copper(I) acetylide complexes [Cu...
Figure 5: Acetylide-bridged dicopper complexes with tris(heteroarylmethyl)amine ligand(s) as key intermediate...
Scheme 19: Off-cycle equilibrium between unreactive polymeric copper(I) acetylide species (right) and reactive...
Figure 6: Categories of tris(heteroarylmethyl)amine ligands regarding their binding ability to copper(I) ions ...
Scheme 20: Mechanistic scheme for ligand-accelerated catalysis with tripodal tris(heteroarylmethyl)amine ligan...
Scheme 21: Synthesis of supposed intermediates in the CuAAC’s catalytic cycle [164,187].
Figure 7: Tetranuclear copper acetylide complexes as reported by Weiss (left) [176] and Tasker (middle) [185] and model...
Figure 8: Gibbs free energy diagram for the computed mechanistic pathway of the CuAAC reaction starting from ...
Figure 9: Energy diagram by Ahlquist and Fokin [125].
Scheme 22: Mechanistic proposal for the CuAAC reaction based on DFT calculations by Fokin [125] and our group [186] ([Cu...
Figure 10: ORTEP plot [202,203] of the X-ray powder diffraction crystal structure of (phenylethynyl)copper(I) [(PhC≡CCu)...
Scheme 23: Synthesis of [(PhC≡CCu)2]n as co-product in the Glaser coupling of phenylacetylene in the presence ...
Scheme 24: Mechanistic explanation for the isotopic enrichment in the product triazolide in the presence of th...
Scheme 25: Homogeneous CuAAC catalysis with a bistriazolylidene dicopper complex (0.5 mol %) and comparison wi...
Beilstein J. Org. Chem. 2013, 9, 1352–1382, doi:10.3762/bjoc.9.153
Graphical Abstract
Figure 1: Qualitative orbital diagram for a d8 metal in ML4 square-planar and ML3 T-shaped complexes.
Figure 2: Walsh diagram for the d-block of a d8 ML3 complex upon bending of one L–M–L angle.
Figure 3: Neutral Y-shaped Pt complex Y1 [15]. Angles are given in degrees.
Figure 4: General classification of T-shaped Pt(II) structures according to the fourth coordination site.
Figure 5: Hydride, boryl and borylene true T-shaped Pt(II) complexes.
Figure 6: NHC-based true T-shaped Pt(II) complexes.
Figure 7: Phosphine-based agostic T-shaped Pt(II) complexes. Compounds in brackets correspond with hydrido–al...
Figure 8: Phenylpyridine and NHC-based agostic T-shaped Pt(II) complexes.
Figure 9: Counteranion coordination in T-shaped Pt(II) complexes.
Figure 10: Phosphine-based solvento Pt(II) complexes.
Figure 11: Nitrogen-based solvento Pt(II) complexes.
Figure 12: Pincer-based solvento Pt(II) complexes.
Figure 13: Structure of the QM/MM optimized cisplatin–protein adduct [94].
Figure 14: NMR coupling constants used for the characterization of three-coordinate Pt(II) species.
Figure 15: The chemical formula of the complexes discussed in Table 2.
Scheme 1: Halogen abstraction from 1.
Scheme 2: Halogen abstraction from 2 forming the dicationic complex T3 [22].
Scheme 3: Hydrogenation of complexes A5a and A5b [39].
Scheme 4: Hydrogenation of complexes 3 and A5c [40].
Scheme 5: Intermolecular C–H bond activation from T5a [28].
Scheme 6: Protonation of complexes 4 [35,36].
Scheme 7: Cyclometalation of 5 [43].
Scheme 8: Protonation of 6.
Scheme 9: Reductive elimination of ethane from 7.
Scheme 10: Reductive elimination of methane from six-coordinate Pt(IV) complexes.
Scheme 11: Proposed dissociative mechanism for the fluxional motion of dmphen in [Pt(Me)(dmphen)(PR3)]+ comple...
Figure 16: Feasible interactions for unsaturated intermediates 11b (left) and 12b (right) during fluxional mot...
Scheme 12: Halogen abstraction from 13a,b and subsequent cyclometalation to yield complexes A5a,b [39].
Scheme 13: Proposed mechanism for the acid-catalyzed cyclometalation of 14 via intermediate 15 [41].
Scheme 14: Proposed mechanism for the formation of 19 [102].
Scheme 15: Cyclometalation of 20 via thioether dissociation [117].
Figure 17: Gibbs energy profile (in chloroform solvent) for the cyclometalation of 23 [120].
Scheme 16: Coordination of tmtu to 29 and subsequent C–H bond activation via three-coordinate species 31 and 32...
Scheme 17: Cyclometalation process of NHC-based Pt(II) complexes [28,44].
Scheme 18: Cyclometalation process of complex A9 [43].
Scheme 19: “Rollover” reaction of 38 and subsequent oligomerization [123].
Scheme 20: Proposed mechanism for the formation of cyclometalated species 44 [124].
Scheme 21: Self-assembling process of 45 by “rollover” reaction [126].
Scheme 22: “Rollover” reaction of A9. Energies (solvent) in kcal mol−1 [127].
Scheme 23: Proposed mechanisms for the “rollover” cyclometalation of 52 in gas-phase ion-molecule reactions [128].
Scheme 24: β-H elimination and 1,2-insertion equilibrium involving A1d and the subsequent generation of 57 [35].
Scheme 25: Proposed mechanism for thermolysis of 7b and 7c in benzene-d6 and cyclohexane-d12 solvents [101].
Scheme 26: β-H elimination process of A11a [28].
Scheme 27: Intermolecular C–H bond activation from 62 [95].
Scheme 28: Reductive elimination of methane from 65 followed by CD3CN coordination or C–D bond-activation proc...
Figure 18: DFT-optimized structures describing the κ2 (69, left) and κ3 (69’, right) coordination modes of [Pt...
Scheme 29: Intermolecular arene C–H bond activation from NHC-based complexes [28].
Figure 19: Energy profiles (in benzene solvent) for the benzene C–H bond activation from A11a, A11b, T5a and T...
Scheme 30: Intermolecular arene C–H bond activation from PNP-based complex 71 [12].
Scheme 31: Intermolecular C–H bond-activation by gas-phase ion-molecule reactions of 74 [7,142].
Scheme 32: Dihydrogen activation through complexes A5a, A5b [39], A5c [40] and S1a [54].
Scheme 33: Dihydrogen activation through complexes A7 and 16 [41]. For a: see Scheme 13.
Scheme 34: Br2 and I2 bond activations through complexes A11a and T5a [143].
Scheme 35: Detection and isolation of the Pt(III) complex 81a [143].
Scheme 36: Cl2 bond activation through complexes 82 and 83 [144].
Scheme 37: cis–trans Isomerization mechanism of the solvento Pt(II) complexes S5 [2,61].
Figure 20: Energy profiles for the isomerization of complexes [Pt(R)(PMe3)2(NCMe)]+ where R means Me (85a, red...
Figure 21: DFT-optimized structure of intermediate 86 [62]. Bond distances in angstrom and angles in degrees.
Scheme 38: Proposed dissociative ligand-substitution mechanism of cis-[Pt(R)2S2] complexes (87) [117].
Scheme 39: Proposed mechanisms for the ligand substitution of the dinuclear species 91 [146].